CiTE antibody for AML

Keyphrases

• T Cells 100%
• Acute Myeloid Leukemia 100%
• CD33 100%
• T Cell Activation 50%
• Extracellular Domain 50%
• Programmed Death-ligand 1 (PD-L1) 50%
• Cytotoxicity 50%
• Bispecific T-cell Engager (BiTE) 50%
• Checkpoint Blockade 50%
• Immune-related Adverse Events 50%
• Anti-PD-1 50%
• Anti-PD-1 Monoclonal Antibody 50%
• Murine Xenograft Model 50%
• Off-tumor Effect 50%

Immunology and Microbiology

• T Cell 100%
• Myeloid 100%
• CD33 100%
• T Cell Activation 50%
• Monoclonal Antibody 50%
• Xenograft 50%
• Cytotoxicity 50%
• Programmed Death-Ligand 1 50%
• Programmed Death 1 Receptor 50%
• CD3 Antigen 50%
• In Vitro 50%

Biochemistry, Genetics and Molecular Biology

• T Cell 100%
• Myeloid 100%
• CD33 66%
• Cell Death 33%
• Monoclonal Antibody 33%
• Synapsin I 33%
• Cell Activation 33%
• Cytotoxicity 33%
• PD-L1 33%